• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

    6/6/25 6:00:38 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Guardian Pharmacy Services, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    40145W101

    (CUSIP Number)


    05/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    40145W101


    1Names of Reporting Persons

    Nuveen Asset Management, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    69,312.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    69,312.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    69,312.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.31 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Guardian Pharmacy Services, Inc.
    (b)Address of issuer's principal executive offices:

    300 Galleria Parkway SE, Suite 800 Atlanta, GA, 30339 United States
    Item 2. 
    (a)Name of person filing:

    Nuveen Asset Management, LLC ("NAM")
    (b)Address or principal business office or, if none, residence:

    333 W. Wacker Drive Chicago, IL 60606
    (c)Citizenship:

    Delaware
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    40145W101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    547,739
    (b)Percent of class:

    2.41%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    69,312

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    69,312

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Nuveen Asset Management, LLC ("NAM"), is a registered investment adviser affiliated with TCIM and TAL. NAM may be deemed to be a beneficial owner of 69,312 shares of Issuer's common stock. TIAA-CREF Investment Management, LLC ("TCIM") is the investment adviser to the College Retirement Equities Fund ("CREF"), a registered investment company, and may be deemed to be a beneficial owner of 467,986 shares of Issuer's common stock owned by CREF. Teachers Advisors, LLC ("TAL") is the investment adviser to three registered investment companies, TIAA-CREF Funds ("Funds"), TIAA-CREF Life Funds ("Life Funds"), and TIAA Separate Account VA-1 ("VA-1"), as well as one or more separately managed accounts of Advisors (collectively, the "Separate Accounts"), and may be deemed to be a beneficial owner of 10,441 shares of Issuer's common stock owned separately by Funds, Life Funds, VA-1, and/or the Separate Accounts.. These shares were acquired in the ordinary course of business, and not with the purpose or effect of changing or influencing control of the Issuer.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Nuveen Asset Management, LLC
     
    Signature:/s/ Erik Mogavero
    Name/Title:Erik Mogavero Managing Director Head of Affiliate Compliance
    Date:06/06/2025
    Get the next $GRDN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      11/20/24 4:05:12 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:48:50 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Patchett Mary Sue bought $49,994 worth of shares (3,571 units at $14.00) and was granted 3,571 shares (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      10/1/24 5:46:36 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      6/6/25 6:01:48 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      6/6/25 6:00:38 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SCHEDULE 13G/A filed by Guardian Pharmacy Services Inc.

      SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      6/6/25 6:01:13 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      12/6/24 12:05:09 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 4:30:13 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

      SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

      11/14/24 1:01:24 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    See more
    • Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

      5/8/25 4:05:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

      Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

      12/17/24 9:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Guardian Pharmacy Services Expands Pacific Northwest Footprint with Acquisition of Washington-based Mercury Pharmacy Services

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced its acquisition of Mercury Pharmacy Services, a leading LTC pharmacy based in Mountlake Terrace, Wash. This acquisition marks Guardian's first pharmacy location in Washington and represents one of the company's larger recent single-pharmacy deals. With this strategic addition, Guardian expands its footprint into the Pacific Northwest, positioning the company to support the growing demand for LTC pharmacy services across this area. The new location will serve residents in assisted living, skilled nursing, and behavioral health communi

      6/2/25 8:07:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of the previously announced underwritten public offering (the "Offering") of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be issued and sold by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of Class A common stock at the public offering price, less the underwriting discount. The Offering i

      5/22/25 11:15:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

      Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the launch of a proposed underwritten public offering (the "Offering") of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30‑day option to purchase up to an additional 1,125,000 shares of Class A common stock at the public offering price, less the underwriting discount. The proposed Offering is considered non-dilutive as Guardian int

      5/20/25 4:16:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    See more

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Guardian Pharmacy Services Expands Midwest Long-Term Care Footprint with Wichita, Kansas Pharmacy Acquisition

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Senior Care Pharmacy in Wichita, Kan. The acquisition expands Guardian's operations into south central and southwest Kansas, strengthening its overall presence across the state and enabling it to bring its high-quality pharmacy services to residents in assisted living, skilled nursing and behavioral health communities, as well as individuals with intellectual and developmental disabilities in these newly served areas. With the addition of the Wichita location, Guardian now operates two pharmacies in Kansas – Kansa

      5/14/25 10:03:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

      4/30/25 4:12:00 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

      Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245-3047 for U.S. participants, or (203) 518-9765 for international participants, and referencing conference ID "Guardian." A replay will be available shortly after the call's completion and remain available for approximately 60

      10/30/24 8:00:00 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

      Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

      10/21/24 8:25:47 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Truist initiated coverage on Guardian Pharmacy Services with a new price target

      Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

      10/21/24 7:42:42 AM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Forbes Kendall sold $8,367,388 worth of shares (415,049 units at $20.16), decreasing direct ownership by 67% to 203,906 units (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/29/25 4:15:03 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Bindley William E sold $83,872,837 worth of shares (4,160,359 units at $20.16) (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/29/25 4:15:11 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Director Salentine Thomas J Jr sold $83,872,837 worth of shares (4,160,359 units at $20.16) (SEC Form 4)

      4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

      5/29/25 4:15:06 PM ET
      $GRDN
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples